nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aldehyde oxidase and its role as a drug metabolizing enzyme
|
Dalvie, Deepak |
|
2019 |
201 |
C |
p. 137-180 |
artikel |
2 |
A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics
|
Cox, Emily J. |
|
2019 |
201 |
C |
p. 25-38 |
artikel |
3 |
An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy
|
Wang, Yi |
|
2019 |
201 |
C |
p. 77-93 |
artikel |
4 |
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
|
Suurs, Frans V. |
|
2019 |
201 |
C |
p. 103-119 |
artikel |
5 |
A review on the pathophysiology of asthma remission
|
Carpaij, Orestes A. |
|
2019 |
201 |
C |
p. 8-24 |
artikel |
6 |
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
|
Stone, Meredith L. |
|
2019 |
201 |
C |
p. 202-213 |
artikel |
7 |
Differential impacts of brain stem oxidative stress and nitrosative stress on sympathetic vasomotor tone
|
Chan, Julie Y.H. |
|
2019 |
201 |
C |
p. 120-136 |
artikel |
8 |
DPP-4 inhibition: А novel therapeutic approach to the treatment of pulmonary hypertension?
|
Anderluh, Marko |
|
2019 |
201 |
C |
p. 1-7 |
artikel |
9 |
Editorial Board
|
|
|
2019 |
201 |
C |
p. ii |
artikel |
10 |
Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications
|
Solouki, Sabrina |
|
2019 |
201 |
C |
p. 39-50 |
artikel |
11 |
Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration
|
Clark, Andrew R. |
|
2019 |
201 |
C |
p. 181-201 |
artikel |
12 |
Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies
|
Murai, Junko |
|
2019 |
201 |
C |
p. 94-102 |
artikel |
13 |
Targeting opioid dysregulation in depression for the development of novel therapeutics
|
Browne, Caroline A. |
|
2019 |
201 |
C |
p. 51-76 |
artikel |